Musculoskeletal Transplant Foundation Inc
Public records show a registered, tax-exempt organization in good standing.
What it says it does
SEE SCHEDULE O
- Income
- $509.5 million
- Spending
- $491.1 million
- Spent on programs
- 91%
- Reserves
- 2.2 months of spending
- Largest source of income
- fees for its services, 97%
- Employees
- 1,309
- Volunteers
- 14
- Highest pay
- $958,758, president / ceo
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Financial health
Fair: 60 out of 100. Higher than 47% of charities in its peer group (health care, over $100m).
Reserves
10 of 35Spendable reserves would cover 2.2 months of spending.
Debt
5 of 20It owes 61% of what it owns.
Living within its means
15 of 15Income exceeded spending by 4% of income.
Income trend
15 of 15Income rose 3% on the year before.
Spending floor
15 of 1591% of spending went to programs and raising each dollar of donations cost 0 cents.
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Governance
Strong: 100 out of 100. Higher than 53% of charities in its peer group (health care, over $100m).
Independent board
25 of 258 of 10 voting board members are independent.
Conflict of interest policy
15 of 15Has a written conflict of interest policy.
Whistleblower policy
8 of 8Has a written whistleblower policy.
Record keeping policy
7 of 7Has a written policy on keeping and destroying records.
Board minutes
5 of 5Keeps minutes of board meetings.
Board sees the tax return
10 of 10Gave the board a copy of this return before filing it.
Pay set independently
5 of 5Sets its chief executive's pay through independent review and comparison.
Independent check of accounts
15 of 15Its accounts were audited by an independent accountant.
No reported misuse
10 of 10Reports no diversion of assets, excess benefits or loans to insiders.
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Impact evidence
Describes programs. Its tax return describes what it does but we have found no measurable results in it.
Programs described in its return (1)
- $446.7 million spent. MTF IS A GLOBAL NONPROFIT ORGANIZATION FOCUSED ON SAVING AND HEALING LIVES, EXPANDING INNOVATION POTENTIAL, HONORING DONATED GIFTS AND SERVING PATIENTS. MTF CONTINUES TO PROVIDE RESEARCH TISSUE AND GRANT FUNDING FOR RESEARCH AND DEVELOPMENT PERFORMED BY ACADEMIC CENTERS AND PIONEERING ENTERPRISES.IN 2024 MTF CONTINUED TO PURSUE ITS MISSION, AND MADE TISSUE FORMS AVAILABLE IN THE ORTHOPEDIC, PLASTIC AND RECONSTRUCTIVE SURGERY, AND WOUND CARE MARKETS THROUGH BOTH INTERNAL AND EXTERNAL DISTRIBUTION RELATIONSHIPS. MTF ORTHOPEDICS FOSTERED NEW PARTNERSHIPS AND EXPANDED (SEE SCHEDULE O)ITS REACH BY LAUNCHING MULTIPLE NEW TISSUE FORMS IN 2024. THESE INNOVATIONS POSITIONED THE FOUNDATION AND OUR PARTNERS TO HELP MORE PATIENTS, WHILE FURTHER MAXIMIZING THE GIFT OF DONATION. MTF ALSO IMPLEMENTED PROCESS EFFICIENCIES THAT WILL CONTINUE TO UTILIZE THE GIFT OF DONATION AND ALLOWS OUR SURGEON COLLABORATORS TO ELEVATE THEIR CONTINUUM OF CARE. IN THE PLASTIC AND RECONSTRUCTIVE SURGERY DIVISION, MTF CONTINUED TO INNOVATE IN PLASTIC SURGERY, WHILE PROVIDING SURGEON EDUCATION AND TRAINING. CONTINUED FOCUS WAS PLACED ON PROCESSING EFFICIENCIES AND DONOR RECOVERY METHODS TO MAXIMIZE THE GIFT OF DONATION WITH THE HELP OF ORGAN PROCUREMENT ORGANIZATIONS. MTF CONTINUED TO BOLSTER ITS INTER-INDUSTRY PARTNERSHIPS,INCREASING THE AVAILABILITY OF DONATED HUMAN TISSUE, AND THE ABILITY TO BRING HUMAN TISSUE ALLOGRAFTS TO SURGEONS AND PATIENTS. MTF'S WOUND CARE DIVISION CONTINUED GROWING THROUGHOUT 2024, EXPANDING ITS PRESENCE IN THE WOUND HEALING SPACE.MTF GENERATED MORE CLINICAL EFFICACY DATA, AS WELL AS HEALTH CARE ECONOMIC DATA FOR EXPANDED REIMBURSEMENT IN WOUND CARE AND PLASTIC AND RECONSTRUCTIVE SURGERY PROCEDURES, FURTHER ILLUSTRATING THE SAFETY AND VALUE OF ITS TISSUE FORMS.DURING 2024, MTF MAINTAINED ITS COMMITMENT TO ADVANCING KEY PROGRAMS, WITH SIGNIFICANT INVESTMENTS IN THE FOLLOWING AREAS:TISSUE RECOVERY AND PROCESSING: $203,669,233TISSUE DISTRIBUTION: $228,708,012RESEARCH AND DEVELOPMENT: $15,307,466THESE EFFORTS REFLECT MTF'S ONGOING DEDICATION TO SUPPORTING TISSUE DONATION, ENSURING EFFICIENT DISTRIBUTION, AND DRIVING INNOVATION THROUGH RESEARCH.OUR GOAL IS SIMPLE-DO WHAT'S RIGHT FOR PATIENTS, SURGEONS, TISSUE DONORS, AND THEIR FAMILIES THROUGH OUR GUIDING PRINCIPLES:1) WE TRANSFORM BY PROVIDING SAFE, HIGH-QUALITY GRAFTS FROM DONATED HUMAN TISSUES THAT ARE USED IN A GROWING ARRAY OF CLINICAL FIELDS.2) WE COLLABORATE BY FORGING RELATIONSHIPS WITH EXPERTS IN TISSUE AND ORGAN RECOVERY, AS WELL AS LEADING PHYSICIANS AND SCIENTISTS, TO ACCELERATE INNOVATION AND ENSURE THE BEST POSSIBLE EXPERIENCES AND OUTCOMES FOR PATIENTS.3) WE INNOVATE BY ADVANCING THE SCIENCE OF TRANSPLANTATION BY SUPPORTING RESEARCH WITHIN OUR OWN ORGANIZATION AND AMONG CLINICIANS AND RESEARCHERS WORLDWIDE.4) WE GIVE BACK BY REINVESTING IN RESEARCH TO POSITIVELY AFFECT LIVES ACROSS THE GLOBE. SINCE ITS INCEPTION IN 1987, MTF, THE NATION'S LEADING TISSUE BANK, HAS RECEIVED TISSUE DONATIONS FROM OVER 170,000 DONORS. IN 2024, MTF RECOVERED TISSUE FROM OVER 5,600 DONORS FOR USE IN MUSCULOSKELETAL AND BONE ALLOGRAFT APPLICATIONS, OVER 7,500 DONORS FOR USE IN GENERAL, AND PLASTIC SURGERY APPLICATIONS, OVER 800 BIRTH TISSUE DONORS FOR USE PREDOMINANTLY IN WOUND CARE APPLICATIONS AND OVER 800 DONORS FOR ORGANS AND TISSUES FOR RESEARCH. OVERALL, MTF DISTRIBUTED OVER 550,000 UNITS OF ALLOGRAFT TISSUE DURING 2024.MTF'S MISSION IS TO SAVE AND HEAL LIVES BY HONORING THE DONATED GIFT, SERVING PATIENTS AND ADVANCING SCIENCE.FOR INDIVIDUAL STORIES ABOUT DONOR FAMILIES, PLEASE VISIT MTF BIOLOGICS WEBSITE AT: HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORSCOMMUNITY/ DONORS-FAMILIES. STORIESABOUT RECIPIENTS ARE ALSO AVAILABLE ON THE WEBSITE AT: HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORSCOMMUNITY/ RECIPIENTS
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Legitimacy checks
Is it registered with the IRS? Passed.
Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.
Has the IRS revoked its tax-exempt status? Passed.
Not on the IRS automatic revocation list.
Source: Automatic revocation of exemption list, Internal Revenue Service, file dated September 30, 2026.
Are donations tax-deductible? Passed.
On the IRS list of organizations eligible to receive tax-deductible contributions.
Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated September 10, 2026.
Is it keeping up with its IRS filings? Passed.
Most recent return on file covers the year ending December 2024.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.
How long has it been tax-exempt? Passed.
Recognized by the IRS since May 1996.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.
Is it in good standing with state regulators? Passed.
Not on California's list of charities barred from soliciting. Other states are not yet checked.
Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 7, 2026.
Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.